ATE179603T1 - Pharmazeutische zusammensetzung zur behandlung der zerebralthrombose - Google Patents
Pharmazeutische zusammensetzung zur behandlung der zerebralthromboseInfo
- Publication number
- ATE179603T1 ATE179603T1 AT94905825T AT94905825T ATE179603T1 AT E179603 T1 ATE179603 T1 AT E179603T1 AT 94905825 T AT94905825 T AT 94905825T AT 94905825 T AT94905825 T AT 94905825T AT E179603 T1 ATE179603 T1 AT E179603T1
- Authority
- AT
- Austria
- Prior art keywords
- cerebral thrombosis
- pharmaceutical composition
- treatment
- optionally substituted
- composition
- Prior art date
Links
- 206010008132 Cerebral thrombosis Diseases 0.000 title abstract 3
- 201000001429 Intracranial Thrombosis Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- JANVYOZZTKSZGN-WCAFQOMDSA-N 5-[(3as,5r,6r,6as)-5-hydroxy-6-[(e,3s)-3-hydroxyoct-1-enyl]-1,3a,4,5,6,6a-hexahydropentalen-2-yl]pentanoic acid Chemical compound C1=C(CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 JANVYOZZTKSZGN-WCAFQOMDSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1632193 | 1993-02-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE179603T1 true ATE179603T1 (de) | 1999-05-15 |
Family
ID=11913225
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94905825T ATE179603T1 (de) | 1993-02-03 | 1994-02-02 | Pharmazeutische zusammensetzung zur behandlung der zerebralthrombose |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5610182A (de) |
| EP (1) | EP0634171B1 (de) |
| JP (1) | JP2851704B2 (de) |
| KR (1) | KR100255992B1 (de) |
| CN (1) | CN1101781A (de) |
| AT (1) | ATE179603T1 (de) |
| AU (1) | AU670494B2 (de) |
| CA (1) | CA2133418A1 (de) |
| DE (1) | DE69418255T2 (de) |
| DK (1) | DK0634171T3 (de) |
| ES (1) | ES2131674T3 (de) |
| GR (1) | GR3030753T3 (de) |
| SG (1) | SG55008A1 (de) |
| WO (1) | WO1994017804A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0761225A4 (de) * | 1994-06-02 | 2002-07-24 | Teijin Ltd | Pharmazeutisches präparat zur behandlung von peripheren durchblutungsstörungen |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3315356A1 (de) * | 1982-04-30 | 1983-11-17 | Ono Pharmaceutical Co. Ltd., Osaka | Verwendung von prostaglandinanalogen |
| JPS58222014A (ja) * | 1982-06-18 | 1983-12-23 | Taisho Pharmaceut Co Ltd | プロスタグランジンｅ↓１脂肪乳剤 |
| JPS59122423A (ja) * | 1982-12-28 | 1984-07-14 | Green Cross Corp:The | 制癌剤含有脂肪乳剤 |
| JPS59141518A (ja) * | 1983-02-03 | 1984-08-14 | Taisho Pharmaceut Co Ltd | プロスタグランジン脂肪乳剤 |
| JPS59210044A (ja) * | 1983-05-13 | 1984-11-28 | Teijin Ltd | プロスタサイクリン類の製法 |
| JPS61197518A (ja) * | 1985-02-27 | 1986-09-01 | Teijin Ltd | プロスタサイクリン類を活性成分として含有する血小板凝集抑制剤 |
| JPS61289034A (ja) * | 1985-06-17 | 1986-12-19 | Teijin Ltd | イソカルバサイクリン類脂肪乳剤 |
| DE3883206T3 (de) * | 1987-09-07 | 2003-11-13 | Teijin Ltd., Osaka | Arzneistoff enthaltende fettemulsion des typs "kurz vor gebrauch hergestellt" sowie verfahren zur herstellung einer arzneihaltigen fettemulsion. |
| EP0402477B1 (de) * | 1988-12-23 | 1997-03-19 | Teijin Limited | Verwendung von isokarbacyclinen zur vorbeugung oder behandlung von organkrankheiten |
| JP2926749B2 (ja) * | 1989-04-25 | 1999-07-28 | 吉富製薬株式会社 | プロスタグランジン含有液状組成物 |
| CA2030345C (en) * | 1989-11-22 | 1998-12-08 | Ryuji Ueno | Use of 15-keto-prostaglandin compound for improvement of encephalic function |
| JPH04342530A (ja) * | 1991-04-26 | 1992-11-30 | Teijin Ltd | ７−フルオロプロスタサイクリン類脂肪乳剤 |
| CN1102039A (zh) * | 1993-02-03 | 1995-04-26 | 帝人株式会社 | 含有异碳环素作为活性成分的外用皮肤治疗剂组合物 |
-
1994
- 1994-02-02 CA CA002133418A patent/CA2133418A1/en not_active Abandoned
- 1994-02-02 AT AT94905825T patent/ATE179603T1/de not_active IP Right Cessation
- 1994-02-02 AU AU59782/94A patent/AU670494B2/en not_active Ceased
- 1994-02-02 DE DE69418255T patent/DE69418255T2/de not_active Expired - Fee Related
- 1994-02-02 US US08/313,244 patent/US5610182A/en not_active Expired - Fee Related
- 1994-02-02 EP EP94905825A patent/EP0634171B1/de not_active Expired - Lifetime
- 1994-02-02 SG SG1996001685A patent/SG55008A1/en unknown
- 1994-02-02 CN CN94190037A patent/CN1101781A/zh active Pending
- 1994-02-02 JP JP6517869A patent/JP2851704B2/ja not_active Expired - Fee Related
- 1994-02-02 ES ES94905825T patent/ES2131674T3/es not_active Expired - Lifetime
- 1994-02-02 KR KR1019940703338A patent/KR100255992B1/ko not_active IP Right Cessation
- 1994-02-02 WO PCT/JP1994/000142 patent/WO1994017804A1/ja active IP Right Grant
- 1994-02-02 DK DK94905825T patent/DK0634171T3/da active
-
1999
- 1999-07-14 GR GR990401838T patent/GR3030753T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2131674T3 (es) | 1999-08-01 |
| WO1994017804A1 (en) | 1994-08-18 |
| KR100255992B1 (ko) | 2000-05-01 |
| DK0634171T3 (da) | 1999-11-01 |
| AU5978294A (en) | 1994-08-29 |
| SG55008A1 (en) | 1998-12-21 |
| EP0634171A4 (de) | 1995-05-03 |
| JPH09500907A (ja) | 1997-01-28 |
| CN1101781A (zh) | 1995-04-19 |
| US5610182A (en) | 1997-03-11 |
| KR950700741A (ko) | 1995-02-20 |
| EP0634171A1 (de) | 1995-01-18 |
| CA2133418A1 (en) | 1994-08-04 |
| EP0634171B1 (de) | 1999-05-06 |
| GR3030753T3 (en) | 1999-11-30 |
| DE69418255D1 (de) | 1999-06-10 |
| JP2851704B2 (ja) | 1999-01-27 |
| AU670494B2 (en) | 1996-07-18 |
| DE69418255T2 (de) | 1999-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE198891T1 (de) | Thienobenzodiazepinderivate zur behandlung von störungen des zentralnervensystems | |
| UA39936C2 (uk) | 2-(2,6-дифторфеніл)-4-(2-етокси-4-трет-бутилфеніл)-2-оксазолін, спосіб мiтицидної обробки та мiтицидна композиція | |
| ATE173630T1 (de) | Behandlung von entzündlichen darmerkrankungen mit interferon-gamma-inhibitoren | |
| DE69131345D1 (de) | Behandlung von pruritus mit estern und amiden | |
| ATE206919T1 (de) | Verwendung des wirkstoffs flupirtin zur herstellung eines arzneimittels zur bekämpfung von muskelverspannungen | |
| ATE179892T1 (de) | Verwendung von lipid-gebundener glykoaminoglykanen zur behandlung der rheumatoider arthritis | |
| ATE255880T1 (de) | Verwendung von kokosölfettsäureacylglutamin in reinigungsmitteln | |
| ATE89814T1 (de) | Fettsaeureamide als acyl-coa-inhibitoren: cholesterolacyltransferase. | |
| ATE128143T1 (de) | 17-beta-substituierte-4-aza-5-alpha-androstan-3 one-derivate und verfahren zu ihrer herstellung. | |
| LV10860A (lv) | Fenilalkilaminu iegusanas panemiens | |
| DK0699439T3 (da) | Behandling af sygdomme forårsaget af talgkirtellidelser med acyl-CoA-cholesterolacyltransferaseinhibitorer | |
| ATE150307T1 (de) | Hemmung von seborrhoe und akne | |
| ATE344668T1 (de) | Verfahren und zusammensetzung zur behandlung von stoerungen des fett- und glukosemetabolismus | |
| EP0456209A3 (en) | Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis | |
| PT659427E (pt) | Metodos de aumento da expressao de trombomodulina | |
| DE69418255D1 (de) | Pharmazeutische zusammensetzung zur behandlung der zerebralthrombose | |
| CO4480757A1 (es) | Composicion fungicida sinergica que comprende un compuesto analogo a la estrobilurina | |
| ATE194912T1 (de) | Mittel zur vorsorge und heilung von typ i allergischen krankheiten | |
| MA27496A1 (fr) | Melange et composition fongicides a base d'un derive de triazolopyrimidine et d'amides, et procede de lutte antifongique les utilisant. | |
| DE69528044D1 (de) | Synthese von optisch reiner 4-aryl-2-hydroxytetronic | |
| PL300834A1 (en) | Arylidine 1-azacycloalkanes and aryl alkyl 1-azacycloalkanes, therapeutic agents containing them and method of obtaining sames | |
| BR9911585A (pt) | Compostos derivados a partir de uma alfa-d-xilose, método para a preparação e uso terapêutico | |
| DK0627432T3 (da) | 6-Piperazinyl-1H-pyrazolo(3,4-b)pyridin-3-carboxylsyrer, deres estere, amider og beslægtede forbindelser, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| DK0918742T3 (da) | Med vand blandbare estere af monoglycerider, som har anti-mikrobiel aktivitet | |
| NO995132L (no) | Fremgangsmåte for reduksjon av fibrinogen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |